Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Pediatrics
Published in: European Journal of Pediatrics 8/2017

Open Access 01-08-2017 | Review

Dissecting Kawasaki disease: a state-of-the-art review

Authors: S. M. Dietz, D. van Stijn, D. Burgner, M. Levin, I. M. Kuipers, B. A. Hutten, T. W. Kuijpers

Published in: European Journal of Pediatrics | Issue 8/2017

Login to get access

Abstract

Kawasaki disease (KD) is a pediatric vasculitis with coronary artery aneurysms (CAA) as its main complication. The diagnosis is based on the presence of persistent fever and clinical features including exanthema, lymphadenopathy, conjunctival injection, and changes to the mucosae and extremities. Although the etiology remains unknown, the current consensus is that it is likely caused by an (infectious) trigger initiating an abnormal immune response in genetically predisposed children. Treatment consists of high dose intravenous immunoglobulin (IVIG) and is directed at preventing the development of CAA. Unfortunately, 10–20% of all patients fail to respond to IVIG and these children need additional anti-inflammatory treatment. Coronary artery lesions are diagnosed by echocardiography in the acute and subacute phases. Both absolute arterial diameters and z-scores, adjusted for height and weight, are used as criteria for CAA. Close monitoring of CAA is important as ischemic symptoms or myocardial infarction due to thrombosis or stenosis can occur. These complications are most likely to arise in the largest, so-called giant CAA. Apart from the presence of CAA, it is unclear whether KD causes an increased cardiovascular risk due to the vasculitis itself.
Conclusion: Many aspects of KD remain unknown, although there is growing knowledge on the etiology, treatment, and development and classification of CAA. Since children with previous KD are entering adulthood, long-term follow-up is increasingly important.
What is known:
• Kawasaki disease (KD) is a pediatric vasculitis with coronary artery damage as its main complication.
• Although KD approaches its 50th birthday since its first description, many aspects of the disease remain poorly understood.
What is new:
• In recent years, multiple genetic candidate pathways involved in KD have been identified, with recently promising information about the ITPKC pathway.
• As increasing numbers of KD patients are reaching adulthood, increasing information is available about the long-term consequences of coronary artery damage and broader cardiovascular risk.
Literature
1.
2.
Alphonse MP, Duong TT, Shumitzu C, Hoang TL, McCrindle BW, Franco A, Schurmans S, Philpott DJ, Hibberd ML, Burns J, Kuijpers TW, Yeung RS (2016) Inositol-triphosphate 3-kinase C mediates inflammasome activation and treatment response in Kawasaki disease. J Immunol 197:3481–3489PubMedCrossRef
3.
Baker AL, Gauvreau K, Newburger JW, Sundel RP, Fulton DR, Jenkins KJ (2003) Physical and psychosocial health in children who have had Kawasaki disease. Pediatrics 111:579–583PubMedCrossRef
4.
Breunis WB, Biezeveld MH, Geissler J, Ottenkamp J, Kuipers IM, Lam J, Hutchinson A, Welch R, Chanock SJ, Kuijpers TW (2006) Vascular endothelial growth factor gene haplotypes in Kawasaki disease. Arthritis Rheum 54:1588–1594PubMedCrossRef
5.
Breunis WB, Davila S, Shimizu C, Oharaseki T, Takahashi K, van Houdt M, Khor CC, Wright VJ, Levin M, Burns JC, Burgner D, Hibberd ML, Kuijpers TW, International Kawasaki Disease Genetics C (2012) Disruption of vascular homeostasis in patients with Kawasaki disease: involvement of vascular endothelial growth factor and angiopoietins. Arthritis Rheum 64:306–315PubMedCrossRef
6.
Brown TJ, Crawford SE, Cornwall ML, Garcia F, Shulman ST, Rowley AH (2001) CD8 T lymphocytes and macrophages infiltrate coronary artery aneurysms in acute Kawasaki disease. J Infect Dis 184:940–943PubMedCrossRef
7.
Burgner D, Davila S, Breunis WB, Ng SB, Li Y, Bonnard C, Ling L, Wright VJ, Thalamuthu A, Odam M, Shimizu C, Burns JC, Levin M, Kuijpers TW, Hibberd ML, International Kawasaki Disease Genetics C (2009) A genome-wide association study identifies novel and functionally related susceptibility loci for Kawasaki disease. PLoS Genet 5:e1000319PubMedPubMedCentralCrossRef
8.
9.
Burns JC, Kone-Paut I, Kuijpers T, Shimizu C, Tremoulet A, Arditi M (2017) Review: found in translation: international initiatives pursuing interleukin-1 blockade for treatment of acute Kawasaki disease. Arthritis & rheumatology 69:268–276CrossRef
10.
Campbell AJ, Burns JC (2016) Adjunctive therapies for Kawasaki disease. J Inf Secur 72(Suppl):S1–S5
11.
12.
Chang CJ, Kuo HC, Chang JS, Lee JK, Tsai FJ, Khor CC, Chang LC et al (2013) Replication and meta-analysis of GWAS identified susceptibility loci in Kawasaki disease confirm the importance of B lymphoid tyrosine kinase (BLK) in disease susceptibility. PLoS One 8:e72037PubMedPubMedCentralCrossRef
13.
Chang LY, Lu CY, Shao PL, Lee PI, Lin MT, Fan TY, Cheng AL, Lee WL, Hu JJ, Yeh SJ, Chang CC, Chiang BL, Wu MH, Huang LM (2014) Viral infections associated with Kawasaki disease. J Formos Med Assoc 113:148–154PubMedCrossRef
14.
Chen JJ, Ma XJ, Liu F, Yan WL, Huang MR, Huang M, Huang GY, Shanghai Kawasaki Disease Research G (2016) Epidemiologic features of Kawasaki disease in Shanghai from 2008 through 2012. Pediatr Infect Dis J 35:7–12PubMed
15.
Chen KY, Curtis N, Dahdah N, Kowalski R, Cheung M, Burgner DP (2016) Kawasaki disease and cardiovascular risk: a comprehensive review of subclinical vascular changes in the longer term. Acta Paediatr 105:752–761PubMedCrossRef
16.
Chen S, Dong Y, Kiuchi MG, Wang J, Li R, Ling Z, Zhou T, Wang Z, Martinek M, Purerfellner H, Liu S, Krucoff MW (2016) Coronary artery complication in Kawasaki disease and the importance of early intervention : a systematic review and meta-analysis. JAMA Pediatr 170:1156–1163PubMedCrossRef
17.
Cheung YF, O K, Woo CW, Armstrong S, Siow YL, Chow PC, Cheung EW (2008) Oxidative stress in children late after Kawasaki disease: relationship with carotid atherosclerosis and stiffness. BMC Pediatr 8:20PubMedPubMedCentralCrossRef
18.
Chi H, Huang FY, Chen MR, Chiu NC, Lee HC, Lin SP, Chen WF, Lin CL, Chan HW, Liu HF, Huang LM, Lee YJ (2010) ITPKC gene SNP rs28493229 and Kawasaki disease in Taiwanese children. Hum Mol Genet 19:1147–1151PubMedCrossRef
19.
Chih WL, Wu PY, Sun LC, Lin MT, Wang JK, Wu MH (2016) Progressive coronary dilatation predicts worse outcome in Kawasaki disease. J Pediatr 171:78–82 e71 PubMedCrossRef
20.
Cho JH, Han MY, Cha SH, Jung JH, Yoon KL (2014) Genetic polymorphism of SMAD5 is associated with Kawasaki disease. Pediatr Cardiol 35:601–607PubMedCrossRef
21.
Choi YM, Shim KS, Yoon KL, Han MY, Cha SH, Kim SK, Jung JH (2012) Transforming growth factor beta receptor II polymorphisms are associated with Kawasaki disease. Korean J Pediatr 55:18–23PubMedPubMedCentralCrossRef
22.
Cohen S, Tacke CE, Straver B, Meijer N, Kuipers IM, Kuijpers TW (2012) A child with severe relapsing Kawasaki disease rescued by IL-1 receptor blockade and extracorporeal membrane oxygenation. Ann Rheum Dis 71:2059–2061PubMedCrossRef
23.
Dallaire F, Dahdah N (2011) New equations and a critical appraisal of coronary artery Z scores in healthy children. J Am Soc Echocardiogr 24:60–74PubMedCrossRef
24.
Davies S, Sutton N, Blackstock S, Gormley S, Hoggart CJ, Levin M, Herberg JA (2015) Predicting IVIG resistance in UK Kawasaki disease. Arch Dis Child 100:366–368PubMedCrossRef
25.
de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW (1998) Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 133:254–258PubMedCrossRef
26.
Dietz SM, Tacke CE, de Groot E, Kuipers IM, Hutten BA, Kuijpers TW, Group DKS (2016) Extracardial vasculopathy after Kawasaki disease: a long-term follow-up study. J Am Heart Assoc 5:e003414PubMedPubMedCentral
27.
Dietz SM, Tacke CE, Hutten BA, Kuijpers TW (2015) Peripheral endothelial (dys)function, arterial stiffness and carotid intima-media thickness in patients after Kawasaki disease: a systematic review and meta-analyses. PLoS One 10:e0130913PubMedPubMedCentralCrossRef
28.
Dietz SM, Tacke CE, Kuipers IM, Wiegman A, de Winter RJ, Burns JC, Gordon JB, Groenink M, Kuijpers TW (2015) Cardiovascular imaging in children and adults following Kawasaki disease. Insights Imaging 6:697–705PubMedPubMedCentralCrossRef
29.
Dionne A, Bakloul M, Manlhiot C, McCrindle BW, Hosking M, Houde C, Pepelassis D, Dahdah N (2017) Coronary artery bypass grafting and percutaneous coronary intervention after Kawasaki disease: the pediatric Canadian series. Pediatr Cardiol 38:36–43PubMedCrossRef
30.
Dionne A, Ibrahim R, Gebhard C, Bakloul M, Selly JB, Leye M, Dery J, Lapierre C, Girard P, Fournier A, Dahdah N (2015) Coronary wall structural changes in patients with Kawasaki disease: new insights from optical coherence tomography (OCT). J Am Heart Assoc 4:e001939PubMedPubMedCentralCrossRef
31.
Research committee on Kawasaki Disease (1984) Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo
32.
Duan J, Lou J, Zhang Q, Ke J, Qi Y, Shen N, Zhu B, Zhong R, Wang Z, Liu L, Wu J, Wang W, Gong F, Miao X (2014) A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis. PLoS One 9:e103329PubMedPubMedCentralCrossRef
33.
Duan Y, Wang X, Cheng Z, Wu D, Wu L (2012) Application of prospective ECG-triggered dual-source CT coronary angiography for infants and children with coronary artery aneurysms due to Kawasaki disease. Br J Radiol 85:e1190–e1197PubMedPubMedCentralCrossRef
34.
Durongpisitkul K, Gururaj VJ, Park JM, Martin CF (1995) The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics 96:1057–1061PubMed
35.
Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T (2006) Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149:237–240PubMedCrossRef
36.
Fraison JB, Seve P, Dauphin C, Mahr A, Gomard-Mennesson E, Varron L, Pugnet G et al (2016) Kawasaki disease in adults: observations in France and literature review. Autoimmun Rev 15:242–249PubMedCrossRef
37.
Franco A, Touma R, Song Y, Shimizu C, Tremoulet AH, Kanegaye JT, Burns JC (2014) Specificity of regulatory T cells that modulate vascular inflammation. Autoimmunity 47:95–104PubMedCrossRef
38.
Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW (2016) Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population. J Am Heart Assoc 5:e003289PubMedPubMedCentralCrossRef
39.
Furuyama H, Odagawa Y, Katoh C, Iwado Y, Ito Y, Noriyasu K, Mabuchi M, Yoshinaga K, Kuge Y, Kobayashi K, Tamaki N (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149–154PubMedCrossRef
40.
Gordon CT, Jimenez-Fernandez S, Daniels LB, Kahn AM, Tarsa M, Matsubara T, Shimizu C, Burns JC, Gordon JB (2014) Pregnancy in women with a history of Kawasaki disease: management and outcomes. BJOG 121:1431–1438PubMedPubMedCentralCrossRef
41.
Gordon JB, Daniels LB, Kahn AM, Jimenez-Fernandez S, Vejar M, Numano F, Burns JC (2016) The spectrum of cardiovascular lesions requiring intervention in adults after Kawasaki disease. JACC Cardiovasc Interv 9:687–696PubMedCrossRef
42.
Group JCSJW (2014) Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J: Off J Jpn Circ Soc 78:2521–2562CrossRef
43.
Ha KS, Jang G, Lee J, Lee K, Hong Y, Son C, Lee J (2013) Incomplete clinical manifestation as a risk factor for coronary artery abnormalities in Kawasaki disease: a meta-analysis. Eur J Pediatr 172:343–349PubMedCrossRef
44.
Ha S, Seo GH, Kim KY, Kim DS (2016) Epidemiologic study on Kawasaki disease in Korea, 2007-2014: based on health insurance review & assessment service claims. J Korean Med Sci 31:1445–1449PubMedPubMedCentralCrossRef
45.
Hall GC, Tulloh LE, Tulloh RM (2016) Kawasaki disease incidence in children and adolescents: an observational study in primary care. Br J Gen Pract 66:e271–e276PubMedPubMedCentralCrossRef
46.
Hao S, Jin B, Tan Z, Li Z, Ji J, Hu G, Wang Y, Deng X, Kanegaye JT, Tremoulet AH, Burns JC, Cohen HJ, Ling XB, Pediatric Emergency Medicine Kawasaki Disease Research G (2016) A classification tool for differentiation of Kawasaki disease from other febrile illnesses. J Pediatr 176:114–120 e118 PubMedCrossRef
47.
Harada M, Akimoto K, Ogawa S, Kato H, Nakamura Y, Hamaoka K, Saji T, Shimizu T, Kato T (2013) National Japanese survey of thrombolytic therapy selection for coronary aneurysm: intracoronary thrombolysis or intravenous coronary thrombolysis in patients with Kawasaki disease. Pediatr Int 55:690–695PubMedCrossRef
48.
Harnick DJ, Jayaraman T, Ma Y, Mulieri P, Go LO, Marks AR (1995) The human type 1 inositol 1,4,5-trisphosphate receptor from T lymphocytes. Structure, localization, and tyrosine phosphorylation. J Biol Chem 270:2833–2840PubMedCrossRef
49.
Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591–594PubMedCrossRef
50.
Hoang LT, Shimizu C, Ling L, Naim AN, Khor CC, Tremoulet AH, Wright V, Levin M, Hibberd ML, Burns JC (2014) Global gene expression profiling identifies new therapeutic targets in acute Kawasaki disease. Genome Med 6:541PubMedPubMedCentralCrossRef
51.
Hsueh KC, Lin YJ, Chang JS, Wan L, Tsai YH, Tsai CH, Chen CP, Tsai FJ (2008) Association of vascular endothelial growth factor C-634 g polymorphism in Taiwanese children with Kawasaki disease. Pediatr Cardiol 29:292–296PubMedCrossRef
52.
Hui-Yuen JS, Duong TT, Yeung RS (2006) TNF-alpha is necessary for induction of coronary artery inflammation and aneurysm formation in an animal model of Kawasaki disease. J Immunol 176:6294–6301PubMedCrossRef
53.
Hwang JY, Lee KY, Rhim JW, Youn YS, Oh JH, Han JW, Lee JS, Burgner D (2011) Assessment of intravenous immunoglobulin non-responders in Kawasaki disease. Arch Dis Child 96:1088–1090PubMedCrossRef
54.
Iemura M, Ishii M, Sugimura T, Akagi T, Kato H (2000) Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular wall morphology and function. Heart 83:307–311PubMedPubMedCentralCrossRef
55.
Jakob A, Whelan J, Kordecki M, Berner R, Stiller B, Arnold R, von Kries R, Neumann E, Roubinis N, Robert M, Grohmann J, Hohn R, Hufnagel M (2016) Kawasaki disease in Germany: a prospective, population-based study adjusted for underreporting. Pediatr Infect Dis J 35:129–134PubMedCrossRef
56.
Kahn AM, Budoff MJ, Daniels LB, Jimenez-Fernandez S, Cox AS, Gordon JB, Burns JC (2012) Calcium scoring in patients with a history of Kawasaki disease. JACC Cardiovasc Imaging 5:264–272PubMedPubMedCentralCrossRef
57.
58.
Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N, Mizuno Y, Hara T (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953–959PubMedCrossRef
59.
Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, Kazue T, Eto G, Yamakawa R (1996) Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 94:1379–1385PubMedCrossRef
60.
Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi 16:178–222PubMed
61.
Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, Yeung RS et al (2011) Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet 43:1241–1246PubMedCrossRef
62.
Khor CC, Davila S, Shimizu C, Sheng S, Matsubara T, Suzuki Y, Newburger JW, Baker A, Burgner D, Breunis W, Kuijpers T, Wright VJ, Levin M, Hibberd ML, Burns JC, US, International Kawasaki Disease Genetics C (2011) Genome-wide linkage and association mapping identify susceptibility alleles in ABCC4 for Kawasaki disease. J Med Genet 48:467–472PubMedCrossRef
63.
Kim JJ, Hong YM, Sohn S, Jang GY, Ha KS, Yun SW, Han MK, Lee KY, Song MS, Lee HD, Kim DS, Lee JE, Shin ES, Jang JH, Lee YS, Kim SY, Lee JY, Han BG, Wu JY, Kim KJ, Park YM, Seo EJ, Park IS, Lee JK, Korean Kawasaki Disease Genetics C (2011) A genome-wide association analysis reveals 1p31 and 2p13.3 as susceptibility loci for Kawasaki disease. Hum Genet 129:487–495PubMedCrossRef
64.
Kim T, Choi W, Woo CW, Choi B, Lee J, Lee K, Son C, Lee J (2007) Predictive risk factors for coronary artery abnormalities in Kawasaki disease. Eur J Pediatr 166:421–425PubMedCrossRef
65.
King WJ, Schlieper A, Birdi N, Cappelli M, Korneluk Y, Rowe PC (2000) The effect of Kawasaki disease on cognition and behavior. Arch Pediatr Adolesc Med 154:463–468PubMedCrossRef
66.
Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A (2006) Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113:2606–2612PubMedCrossRef
67.
Kuo HC, Chao MC, Hsu YW, Lin YC, Huang YH, Yu HR, Hou MF, Liang CD, Yang KD, Chang WC, Wang CL (2012) CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population. ScientificWorldJournal 2012:520865PubMedPubMedCentralCrossRef
68.
Kuo HC, Hsu YW, Lo MH, Huang YH, Chien SC, Chang WC (2014) Single-nucleotide polymorphism rs7251246 in ITPKC is associated with susceptibility and coronary artery lesions in Kawasaki disease. PLoS One 9:e91118PubMedPubMedCentralCrossRef
69.
Kuo HC, Li SC, Guo MM, Huang YH, Yu HR, Huang FC, Jiao F, Kuo HC, Andrade J, Chan WC (2016) Genome-wide association study identifies novel susceptibility genes associated with coronary artery aneurysm formation in Kawasaki disease. PLoS One 11:e0154943PubMedPubMedCentralCrossRef
70.
Kuo HC, Onouchi Y, Hsu YW, Chen WC, Huang JD, Huang YH, Yang YL, Chao MC, Yu HR, Juan YS, Kuo CM, Yang KD, Huang JS, Chang WC (2011) Polymorphisms of transforming growth factor-beta signaling pathway and Kawasaki disease in the Taiwanese population. J Hum Genet 56:840–845PubMedCrossRef
71.
Kuo HC, Yang KD, Juo SH, Liang CD, Chen WC, Wang YS, Lee CH, Hsi E, Yu HR, Woon PY, Lin IC, Huang CF, Hwang DY, Lee CP, Lin LY, Chang WP, Chang WC (2011) ITPKC single nucleotide polymorphism associated with the Kawasaki disease in a Taiwanese population. PLoS One 6:e17370PubMedPubMedCentralCrossRef
72.
Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, Liang CD, Chi H, Huang FY, Lee ML, Huang YC, Hwang B, Chiu NC, Hwang KP, Lee PC, Chang LC, Liu YM, Chen YJ, Chen CH, Taiwan Pediatric IDA, Chen YT, Tsai FJ, Wu JY (2012) Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet 44:522–525PubMedCrossRef
73.
Lin MT, Wang JK, Yeh JI, Sun LC, Chen PL, Wu JF, Chang CC, Lee WL, Shen CT, Wang NK, Wu CS, Yeh SZ, Chen CA, Chiu SN, Wu MH (2011) Clinical implication of the C allele of the ITPKC gene SNP rs28493229 in Kawasaki disease: association with disease susceptibility and BCG scar reactivation. Pediatr Infect Dis J 30:148–152PubMedCrossRef
74.
Ling XB, Kanegaye JT, Ji J, Peng S, Sato Y, Tremoulet A, Burns JC, Cohen HJ (2013) Point-of-care differentiation of Kawasaki disease from other febrile illnesses. J Pediatr 162:183–188 e183 PubMedCrossRef
75.
Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E (2016) Role of the Egami score in predicting intravenous immunoglobulin resistance in Kawasaki disease among different ethnicities. Am J Ther 23:e1293–e1299PubMedCrossRef
76.
Lou J, Xu S, Zou L, Zhong R, Zhang T, Sun Y, Lu X, Liu L, Li C, Wang L, Xiong G, Wang W, Gong F, Wu J (2012) A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis. Mol Biol Rep 39:11137–11144PubMedCrossRef
77.
Lou J, Zhong R, Shen N, Lu XZ, Ke JT, Duan JY, Qi YQ, Wang YJ, Zhang Q, Wang W, Gong FQ, Miao XP (2015) Systematic confirmation study of GWAS-identified genetic variants for Kawasaki disease in a Chinese population. Sci Rep 5:8194PubMedPubMedCentralCrossRef
78.
Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, Kojo T, Uehara R, Kotani K, Yanagawa H (2015) Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol 25:239–245PubMedCrossRef
79.
Manlhiot C, Millar K, Golding F, McCrindle BW (2010) Improved classification of coronary artery abnormalities based only on coronary artery z-scores after Kawasaki disease. Pediatr Cardiol 31:242–249PubMedCrossRef
80.
Matsubara K, Fukaya T, Miwa K, Shibayama N, Nigami H, Harigaya H, Nozaki H, Hirata T, Baba K, Suzuki T, Ishiguro A (2006) Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease. Clin Exp Immunol 143:427–434PubMedPubMedCentralCrossRef
81.
Mavrogeni S, Papadopoulos G, Douskou M, Kaklis S, Seimenis I, Baras P, Nikolaidou P, Bakoula C, Karanasios E, Manginas A, Cokkinos DV (2004) Magnetic resonance angiography is equivalent to X-ray coronary angiography for the evaluation of coronary arteries in Kawasaki disease. J Am Coll Cardiol 43:649–652PubMedCrossRef
82.
McCrindle BW, Li JS, Minich LL, Colan SD, Atz AM, Takahashi M, Vetter VL, Gersony WM, Mitchell PD, Newburger JW, Pediatric Heart Network I (2007) Coronary artery involvement in children with Kawasaki disease: risk factors from analysis of serial normalized measurements. Circulation 116:174–179PubMedCrossRef
83.
McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu MH, Saji TT, Pahl E, American Heart Association Rheumatic Fever E, Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Y, Council on C, Stroke N, Council on Cardiovascular S, Anesthesia, Council on E, Prevention (2017) Diagnosis, treatment, and long-term management of kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation 135:e927–e999
84.
Muta H, Ishii M (2010) Percutaneous coronary intervention versus coronary artery bypass grafting for stenotic lesions after Kawasaki disease. J Pediatr 157:120–126PubMedCrossRef
85.
Muta H, Ishii M, Iemura M, Matsuishi T (2010) Health-related quality of life in adolescents and young adults with a history of Kawasaki disease. J Pediatr 156:439–443PubMedCrossRef
86.
Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ, Colan SD, Duffy CE, Fulton DR, Glode MP et al (1991) A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324:1633–1639PubMedCrossRef
87.
88.
Nishad P, Singh S, Sidhu M, Malhi P (2010) Cognitive and behaviour assessment following Kawasaki disease—a study from North India. Rheumatol Int 30:851–854PubMedCrossRef
89.
Noto N, Okada T, Karasawa K, Ayusawa M, Sumitomo N, Harada K, Mugishima H (2009) Age-related acceleration of endothelial dysfunction and subclinical atherosclerosis in subjects with coronary artery lesions after Kawasaki disease. Pediatr Cardiol 30:262–268PubMedCrossRef
90.
Olivieri L, Arling B, Friberg M, Sable C (2009) Coronary artery Z score regression equations and calculators derived from a large heterogeneous population of children undergoing echocardiography. J Am Soc Echocardiogr 22:159–164PubMedCrossRef
91.
Onouchi Y (2012) Genetics of Kawasaki disease: what we know and don’t know. Circ J 76:1581–1586PubMedCrossRef
92.
Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, Nakamura Y et al (2008) ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 40:35–42PubMedCrossRef
93.
Onouchi Y, Onoue S, Tamari M, Wakui K, Fukushima Y, Yashiro M, Nakamura Y, Yanagawa H, Kishi F, Ouchi K, Terai M, Hamamoto K, Kudo F, Aotsuka H, Sato Y, Nariai A, Kaburagi Y, Miura M, Saji T, Kawasaki T, Nakamura Y, Hata A (2004) CD40 ligand gene and Kawasaki disease. Eur J Hum Genet 12:1062–1068PubMedCrossRef
94.
Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, Honda T et al (2012) A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet 44:517–521PubMedCrossRef
95.
Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, Suenaga T et al (2013) ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease. Pharmacogenomics J 13:52–59PubMedCrossRef
96.
Parthasarathy P, Agarwal A, Chawla K, Tofighi T, Mondal TK (2015) Upcoming biomarkers for the diagnosis of Kawasaki disease: a review. Clin Biochem 48:1188–1194PubMedCrossRef
97.
Peng Q, Chen C, Zhang Y, He H, Wu Q, Liao J, Li B, Luo C, Hu X, Zheng Z, Yang Y (2012) Single-nucleotide polymorphism rs2290692 in the 3′UTR of ITPKC associated with susceptibility to Kawasaki disease in a Han Chinese population. Pediatr Cardiol 33:1046–1053PubMedCrossRef
98.
Peng Q, Deng Y, Yang X, Leng X, Yang Y, Liu H (2016) Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-beta/SMAD3 signaling pathway. Eur J Pediatr 175:705–713PubMedCrossRef
99.
Phuong LK, Bonetto C, Buttery J, Pernus YB, Chandler R, Goldenthal KL, Kucuku M, Monaco G, Pahud B, Shulman ST, Top KA, Ulloa-Gutierrez R, Varricchio F, de Ferranti S, Newburger JW, Dahdah N, Singh S, Bonhoeffer J, Burgner D, Brighton Collaboration Kawasaki Disease Working G (2016) Kawasaki disease and immunisation: standardised case definition & guidelines for data collection, analysis. Vaccine 34:6582–6596PubMedCrossRef
100.
Reth M, Wienands J (1997) Initiation and processing of signals from the B cell antigen receptor. Annu Rev Immunol 15:453–479PubMedCrossRef
101.
Ronai C, Hamaoka-Okamoto A, Baker AL, de Ferranti SD, Colan SD, Newburger JW, Friedman KG (2016) Coronary artery aneurysm measurement and Z score variability in Kawasaki disease. J Am Soc Echocardiogr: Off Publ Am Soc Echocardiogr 29:150–157CrossRef
102.
Rowley AH, Baker SC, Orenstein JM, Shulman ST (2008) Searching for the cause of Kawasaki disease—cytoplasmic inclusion bodies provide new insight. Nat Rev Microbiol 6:394–401PubMedCrossRef
103.
Rowley AH, Baker SC, Shulman ST, Rand KH, Tretiakova MS, Perlman EJ, Garcia FL, Tajuddin NF, Fox LM, Huang JH, Ralphe JC, Takahashi K, Flatow J, Lin S, Kalelkar MB, Soriano B, Orenstein JM (2011) Ultrastructural, immunofluorescence, and RNA evidence support the hypothesis of a “new” virus associated with Kawasaki disease. J Infect Dis 203:1021–1030PubMedPubMedCentralCrossRef
104.
Sanchez-Manubens J, Anton J, Bou R, Iglesias E, Calzada-Hernandez J, Borlan S, Gimenez-Roca C, Rivera J, Kawasaki Disease in Catalonia Working G (2016) Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population. Rheumatol Int 36:905–910PubMedCrossRef
105.
Sanchez-Manubens J, Anton J, Bou R, Iglesias E, Calzada-Hernandez J, Kawasaki Disease in Catalonia Working G (2016) Incidence, epidemiology and clinical features of Kawasaki disease in Catalonia, Spain. Clin Exp Rheumatol 34:S139–S144PubMed
106.
Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J (2007) Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166:131–137PubMedCrossRef
107.
Selamet Tierney ES, Gal D, Gauvreau K, Baker AL, Trevey S, O’Neill SR, Jaff MR, de Ferranti S, Fulton DR, Colan SD, Newburger JW (2013) Vascular health in Kawasaki disease. J Am Coll Cardiol 62:1114–1121PubMedCrossRef
108.
Shendre A, Wiener HW, Zhi D, Vazquez AI, Portman MA, Shrestha S (2014) High-density genotyping of immune loci in Kawasaki disease and IVIG treatment response in European-American case-parent trio study. Genes Immun 15:534–542PubMedPubMedCentralCrossRef
109.
Shimizu C, Jain S, Davila S, Hibberd ML, Lin KO, Molkara D, Frazer JR et al (2011) Transforming growth factor-beta signaling pathway in patients with Kawasaki disease. Circ Cardiovasc Genet 4:16–25PubMedCrossRef
110.
Shrestha S, Wiener H, Shendre A, Kaslow RA, Wu J, Olson A, Bowles NE, Patel H, Edberg JC, Portman MA (2012) Role of activating FcgammaR gene polymorphisms in Kawasaki disease susceptibility and intravenous immunoglobulin response. Circ Cardiovasc Genet 5:309–316PubMedPubMedCentralCrossRef
111.
Shrestha S, Wiener HW, Olson AK, Edberg JC, Bowles NE, Patel H, Portman MA (2011) Functional FCGR2B gene variants influence intravenous immunoglobulin response in patients with Kawasaki disease. J Allergy Clin Immunol 128:677–680PubMedPubMedCentralCrossRef
112.
Sleeper LA, Minich LL, McCrindle BM, Li JS, Mason W, Colan SD, Atz AM, Printz BF, Baker A, Vetter VL, Newburger JW, Pediatric Heart Network I (2011) Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr 158:831–835 e833 PubMedCrossRef
113.
Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, Newburger JW (2009) Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics 124:1–8PubMedCrossRef
114.
Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J (2009) Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr 168:1315–1321PubMedCrossRef
115.
Song R, Yao W, Li X (2016) Efficacy of four scoring systems in predicting intravenous immunoglobulin resistance in children with Kawasaki disease in a children’s hospital in Beijing, North China. J Pediatr 184:120–124
116.
Suda K, Iemura M, Nishiono H, Teramachi Y, Koteda Y, Kishimoto S, Kudo Y, Itoh S, Ishii H, Ueno T, Tashiro T, Nobuyoshi M, Kato H, Matsuishi T (2011) Long-term prognosis of patients with Kawasaki disease complicated by giant coronary aneurysms: a single-institution experience. Circulation 123:1836–1842PubMedCrossRef
117.
Suenaga T, Suzuki H, Shibuta S, Takeuchi T, Yoshikawa N (2009) Detection of multiple superantigen genes in stools of patients with Kawasaki disease. J Pediatr 155:266–270PubMedCrossRef
118.
Suzuki A, Miyagawa-Tomita S, Komatsu K, Nishikawa T, Sakomura Y, Horie T, Nakazawa M (2000) Active remodeling of the coronary arterial lesions in the late phase of Kawasaki disease: immunohistochemical study. Circulation 101:2935–2941PubMedCrossRef
119.
Suzuki H, Uemura S, Tone S, Iizuka T, Koike M, Hirayama K, Maeda J (1996) Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease. Eur J Pediatr 155:291–296PubMedCrossRef
120.
Tacke CE, Breunis WB, Pereira RR, Breur JM, Kuipers IM, Kuijpers TW (2014) Five years of Kawasaki disease in the Netherlands: a national surveillance study. Pediatr Infect Dis J 33:793–797PubMedCrossRef
121.
Tacke CE, Haverman L, Berk BM, van Rossum MA, Kuipers IM, Grootenhuis MA, Kuijpers TW (2012) Quality of life and behavioral functioning in Dutch children with a history of Kawasaki disease. J Pediatr 161:314–319 e311 PubMedCrossRef
122.
Tacke CE, Romeih S, Kuipers IM, Spijkerboer AM, Groenink M, Kuijpers TW (2013) Evaluation of cardiac function by magnetic resonance imaging during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging 6:67–73PubMedCrossRef
123.
Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, Takahashi H, Kino M, Kobayashi Y (2005) Polymorphism of fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease. J Clin Immunol 25:309–313PubMedCrossRef
124.
Terai M, Shulman ST (1997) Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 131:888–893PubMedCrossRef
125.
Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, Kanegaye JT, Kovalchin JP, Printz BF, Ramilo O, Burns JC (2014) Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet 383:1731–1738PubMedCrossRef
126.
Tsai FJ, Lee YC, Chang JS, Huang LM, Huang FY, Chiu NC, Chen MR, Chi H, Lee YJ, Chang LC, Liu YM, Wang HH, Chen CH, Chen YT, Wu JY (2011) Identification of novel susceptibility loci for Kawasaki disease in a Han Chinese population by a genome-wide association study. PLoS One 6:e16853PubMedPubMedCentralCrossRef
127.
Tsuda E, Hamaoka K, Suzuki H, Sakazaki H, Murakami Y, Nakagawa M, Takasugi H, Yoshibayashi M (2014) A survey of the 3-decade outcome for patients with giant aneurysms caused by Kawasaki disease. Am Heart J 167:249–258PubMedCrossRef
128.
Turnier JL, Anderson MS, Heizer HR, Jone PN, Glode MP, Dominguez SR (2015) Concurrent respiratory viruses and Kawasaki disease. Pediatrics 136:e609–e614PubMedCrossRef
129.
van Oers HA, Tacke CE, Haverman L, Kuipers IM, Maurice-Stam H, Kuijpers TW, Grootenhuis MA (2014) Health related quality of life and perceptions of child vulnerability among parents of children with a history of Kawasaki disease. Acta Paediatr 103:671–677PubMedCrossRef
130.
Yan Y, Ma Y, Liu Y, Hu H, Shen Y, Zhang S, Ma Y, Tao D, Wu Q, Peng Q, Yang Y (2013) Combined analysis of genome-wide-linked susceptibility loci to Kawasaki disease in Han Chinese. Hum Genet 132:669–680PubMedCrossRef
131.
132.
Metadata
Title
Dissecting Kawasaki disease: a state-of-the-art review
Authors
S. M. Dietz
D. van Stijn
D. Burgner
M. Levin
I. M. Kuipers
B. A. Hutten
T. W. Kuijpers
Publication date
01-08-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 8/2017
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-017-2937-5

Other articles of this Issue 8/2017

European Journal of Pediatrics 8/2017 Go to the issue

Original Article

Nail dystrophy due to toe malposition in children

Editorial

Kawasaki disease: what the paediatrician needs to know

Original Article

Determinants of levothyroxine dose required to achieve euthyroidism in pediatric population—a hospital-based prospective follow-up study

Original Article

Rural versus urban compliance in the management of cryptorchidism: is there a difference?

Original Article

Diagnostic accuracy of clinical dehydration scales in children

Original Article

Professionals’ preferences in prenatal counseling at the limits of viability: a nationwide qualitative Dutch study